Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 5.06B 752M 644M 601M 552M 1.04B 71.99B 1.06B 7.13B 2.78B 36.08B 2.83B 2.76B 119B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.89B 727M 623M 581M 533M 1B 69.59B 1.02B 6.89B 2.69B 34.88B 2.73B 2.67B 115B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day+4.82%
1 week+0.93%
Current month+11.40%
1 month+11.83%
3 months-3.87%
6 months-13.09%
Current year+9.57%
1 week 8.26
Extreme 8.26
8.94
1 month 7.15
Extreme 7.15
8.94
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.38
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
14.86
Manager TitleAgeSince
Chief Executive Officer 42 11/12/2017
Director of Finance/CFO 34 01/08/2019
Chief Operating Officer 45 25/08/2022
Director TitleAgeSince
Chairman 42 01/08/2019
Chairman 48 21/03/2019
Director/Board Member 46 21/03/2019
Date Insider Type Main position Quantity % Market Cap.
07/08/26 Sell

Executive/Senior Manager

-2,000 0.0005%
14/09/21 Sell

Executive/Senior Manager

10,000 0.0025%
10/09/21 Sell

Executive/Senior Manager

77,000 0.0189%
Change 5-day change 1-year change 3-year change Capi.($)
+4.82%+0.93%-22.74%+34.88% 717M
-2.58%+3.05%+76.62%+126.51% 1,141B
-1.88%+2.25%+49.84%+60.13% 659B
-1.65%+4.09%+24.83%+73.87% 470B
+1.20%+2.62%+41.69%+46.21% 366B
-0.61%+2.10%+23.43%+40.38% 302B
+0.32%+3.25%+0.94%+13.25% 254B
-2.16%+3.40%+45.73%+65.72% 239B
-1.10%-0.70%-14.31%-53.04% 207B
-2.30%+4.57%+21.66%+90.22% 183B
Average -0.69%+2.98%+24.77%+49.81% 382.17B
Weighted average by Cap. -1.63%+3.04%+43.55%+71.30%

Financials

2024 2025
Net sales 984M 146M 125M 117M 107M 201M 13.99B 205M 1.39B 540M 7.01B 549M 537M 23.22B 1.21B 179M 153M 143M 131M 247M 17.15B 252M 1.7B 662M 8.59B 673M 658M 28.45B
Net income 13.65M 2.03M 1.74M 1.62M 1.49M 2.8M 194M 2.85M 19.24M 7.5M 97.33M 7.62M 7.46M 322M 92.73M 13.79M 11.8M 11.01M 10.11M 18.99M 1.32B 19.36M 131M 50.94M 661M 51.77M 50.64M 2.19B
Net Debt 189M 28.11M 24.07M 22.46M 20.61M 38.72M 2.69B 39.48M 266M 104M 1.35B 106M 103M 4.46B -169M -25.1M -21.49M -20.05M -18.4M -34.57M -2.4B -35.25M -238M -92.72M -1.2B -94.24M -92.19M -3.98B
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
20/08/26 CN¥8.700 +4.82% 34,083,990
19/08/26 CN¥8.300 -3.38% 16,649,500
18/08/26 CN¥8.590 -1.38% 15,169,100
17/08/26 CN¥8.710 -0.23% 20,696,400
14/08/26 CN¥8.730 -0.23% 22,324,100

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock